Indian pharma company Zydus Lifesciences Limited, previously known as Cadila Healthcare Limited has launched Lenalidomide Capsules, a generic of Revlimid, in the US market. The launch of Lenalidomide Capsules follows the final approvals for 5 mg, 10 mg, 15 mg and 25 mg strengths and tentative approvals for 2.5 mg and 20 mg strength from […]
Recent studies by the researchers of Washington University of St Louis along with their German collaborators have found that a compound ‘epigallocatechine-3-gallate’ (EGCG) found in green tea leaves help the patients suffering from bone-marrow disorders. Multiple myeloma and amyloidosis which are the life threatening medical complications associated with bone-marrow disorders can be treated with the […]
